Showing results (171-180 of 318) with videos related to

Sort By:
Pageof 32
Nucleic Acids Research|November 28, 2014
BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmersRyan P Abo, Matthew Ducar, Elizabeth P Garcia, et al.
Cancer|September 30, 2024
The American Cancer Society National Lung Cancer Roundtable strategic plan: Methods for improving turnaround time of comprehensive biomarker testing in non-small cell lung cancerSinchita Roy-Chowdhuri, Haresh Mani, Adam H Fox, et al.
Cancer Research|June 7, 2015
Identification of Oncogenic and Drug-Sensitizing Mutations in the Extracellular Domain of FGFR2Junko Tanizaki, Dalia Ercan, Marzia Capelletti, et al.
JAMA Oncology|July 17, 2015
Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1Brooke E Howitt, Sachet A Shukla, Lynette M Sholl, et al.
Clinical Genitourinary Cancer|February 11, 2024
A Panel-Based Mutational Signature of Mismatch Repair Deficiency is Associated With Durable Response to Pembrolizumab in Metastatic Castration-Resistant Prostate CancerDaniel Boiarsky, Doga C Gulhan, Hunter Savignano, et al.
The Oncologist|February 16, 2018
Cabozantinib in Patients with Advanced Merkel Cell CarcinomaGuilherme Rabinowits, Cecilia Lezcano, Paul J Catalano, et al.
Histopathology|May 5, 2019
Loss of SMAD4 protein expression in gastrointestinal and extra-gastrointestinal carcinomasLauren L Ritterhouse, Elizabeth Yiru Wu, Woo Gyeong Kim, et al.
Elife|September 16, 2020
<i>IER5</i>, a DNA damage response gene, is required for Notch-mediated induction of squamous cell differentiationLi Pan, Madeleine E Lemieux, Tom Thomas, et al.
Lung Cancer (Amsterdam, Netherlands)|May 30, 2021
Rates of invasive disease and outcomes in NSCLC patients with biopsy suggestive of carcinoma in situWesley J Talcott, Joseph A Miccio, Henry S Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2016
MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met OverexpressionMark M Awad, Geoffrey R Oxnard, David M Jackman, et al.
Pageof 32